Near-infrared fluorescence imaging + Indocyanine Green for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Sep 2026: Trial registered, NCT07825597
  2. 30 Sep 2026: Trial started, NCT07825597

The trials

NCT07825597: Indocyanine Green With Near Infrared Imaging for Intraoperative Visualization of Head and Neck Squamous Cell Carcinoma

State
Under way
Phase
Phase 2
People
25 planned
Started
30 Sep 2026
Primary completion
31 Mar 2028
Arms
Head and neck surgical resection cohort
Results
None posted
  1. 17 Sep 2026: Trial registered
  2. 30 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.